Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Amn Healthcare Services, Inc. (AMN)
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-11-04
$47.74+5.39%
Close 2026-11-04 · 1-day change
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.94 → 0.94 EPS · FY ending Dec 31, 2027 · 6 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 6 to 6; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for AMN yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain gross margin near 28% | Gross margin rose from 23.5% to 28.0% in the same period. | Intact | gross margin falls below 23.5% | Gross margin: 30.58% FY2026-Q2; GAAP. Published target: >= 28.0% gross margin. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 6, 202630.58091 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
AMN is a cyclical recovery business, with earnings that can shift as healthcare staffing demand changes. Its multi-year view is intact, but the recent signal has moved from mildly favorable to mixed.
The evidence labels AMN cheap versus peers, while also showing a 0.52 premium versus peers, so the valuation picture is mixed. The expectations gap is negative, but model confidence is low; the evidence does not support a firm conclusion about what the market already assumes.
Near term, management’s margin priorities are on track: gross margin rose year over year and operating results recovered to a profit in 2026-Q2. However, guidance points to lower margins in 2026-Q3, and revenue fell from Q1 as labor disruption effects normalized, despite year-over-year growth in Nurse and Allied Solutions and search.
The near-term thesis is vulnerable if AMN cuts guidance or the jobs report continues to weaken, since recession fears can weigh more heavily on cyclical healthcare names. Continued earnings strength and higher guidance from sector bellwethers could support sector momentum; the evidence also flags erratic, declining earnings surprises.
Over the next 1 to 3 years, the thesis rests on sustained operating improvement and revenue growth while staffing demand normalizes. Recent results support the recovery, but elevated risk and lower near-term margin guidance make the evidence mixed. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 3 of 3 supplied quarters. Management reported: “Consolidated gross margin was 30.6%, 80 basis points higher year over year and up 380 basis points sequentially.” “Full year consolidated gross margin was 28.3% compared with 30.8% for the prior year.”
Improve operating margin from near zero | The company is working to improve profit margin despite recent challenges. | Intact | operating margin falls below 0% | Operating margin: 4% FY2026-Q2; GAAP. Published target: >= 0.1% operating margin. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 6, 20263.996809 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Increase revenue significantly | A primary condition in Amn Healthcare Services, Inc.'s published investment case. The stated target is >= $1.38 billion in revenue in 2026-Q1. | Broken | revenue falls below $689.5 million in any quarter | Revenue: $673.237M FY2026-Q2; GAAP. Published target: >= $1.38 billion in revenue in 2026-Q1. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 6, 2026673,237,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.08 → $0.94 · observed estimates
$2.60B → $2.67B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.08 | $2,604,742,090 | 9 / 9 |
| 2026-07-25 | $1.08 | $2,604,742,090 | 9 / 9 |
| 2026-07-26 | $1.08 | $2,604,742,090 | 9 / 9 |
| 2026-07-27 | $1.08 | $2,604,742,090 | 9 / 9 |
| 2026-07-28 | $1.08 | $2,604,744,387 | 6 / 6 |
| 2026-07-29 | $1.08 | $2,604,742,090 | 9 / 9 |
| 2026-07-30 | $1.08 | $2,604,742,090 | 9 / 9 |
| 2026-07-31 | $1.08 | $2,604,742,090 | 9 / 9 |
| 2026-08-01 | $1.08 | $2,604,742,090 | 9 / 9 |
| 2026-08-02 | $1.08 | $2,604,742,090 | 9 / 9 |
| 2026-08-03 | $1.08 | $2,604,742,090 | 9 / 9 |
| 2026-08-04 | $1.08 | $2,604,742,090 | 9 / 9 |
| 2026-08-05 | $1.08 | $2,604,742,090 | 9 / 9 |
| 2026-08-06 | $1.08 | $2,604,742,090 | 9 / 9 |
| 2026-08-07 | $1.08 | $2,604,744,387 | 6 / 6 |
| 2026-08-08 | $1.04 | $2,622,802,830 | 9 / 9 |
| 2026-08-09 | $1.04 | $2,622,802,830 | 9 / 9 |
| 2026-08-10 | $1.04 | $2,622,802,830 | 9 / 9 |
| 2026-08-11 | $0.93 | $2,637,032,934 | 6 / 6 |
| 2026-08-12 | $0.94 | $2,647,474,410 | 9 / 9 |
| 2026-08-13 | $0.94 | $2,659,559,970 | 9 / 9 |
| 2026-08-14 | $0.93 | $2,637,032,934 | 6 / 6 |
| 2026-08-15 | $0.93 | $2,637,032,934 | 6 / 6 |
| 2026-08-16 | $0.93 | $2,637,032,934 | 6 / 6 |
| 2026-08-17 | $0.93 | $2,637,032,934 | 6 / 6 |
| 2026-08-18 | $0.93 | $2,637,032,934 | 6 / 6 |
| 2026-08-19 | $0.93 | $2,637,032,934 | 6 / 6 |
| 2026-08-20 | $0.93 | $2,637,032,934 | 6 / 6 |
| 2026-08-21 | $0.94 | $2,664,388,301 | 6 / 6 |
| 2026-08-22 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-08-23 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-08-24 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-08-25 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-08-26 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-08-27 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-08-28 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-08-29 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-08-30 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-08-31 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-01 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-02 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-03 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-04 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-05 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-06 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-07 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-08 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-09 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-10 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-11 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-12 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-13 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-14 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-15 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-16 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-17 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-18 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-19 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-20 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-21 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-22 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-23 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-24 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-25 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-26 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-27 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-28 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-29 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-09-30 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-10-01 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-10-02 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-10-03 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-10-04 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-10-05 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-10-06 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-10-07 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-10-08 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-10-09 | $0.94 | $2,664,356,057 | 6 / 6 |
| 2026-10-10 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-11 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-12 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-13 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-14 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-15 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-16 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-17 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-18 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-19 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-20 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-21 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-22 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-23 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-24 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-25 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-26 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-27 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-28 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-29 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-30 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-10-31 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-11-01 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-11-02 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-11-03 | $0.94 | $2,669,487,834 | 6 / 6 |
| 2026-11-04 | $0.94 | $2,669,487,834 | 6 / 6 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 5 Hold · 1 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
1 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.